Comparison between Sudarshan Pharma Industries IPO and Systango Technologies IPO.
Sudarshan Pharma Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Systango Technologies IPO is a SME Bookbuilding proposed to list at NSE SME.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Hem Securities Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sudarshan Pharma Industries IPO is up to ₹47.58 Cr whereas the issue size of the Systango Technologies IPO is up to ₹33.05 Cr. The final issue price of Sudarshan Pharma Industries IPO is ₹73.00 per share and of Systango Technologies IPO is ₹90.00 per share.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹71.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹73.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹73.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 65,18,400 shares | 36,72,000 shares |
| Fresh Issue Size (Amount) | up to ₹47.58 Cr | up to ₹33.05 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 65,18,400 shares | 36,72,000 shares |
| Issue Size Total (Amount) | up to ₹47.58 Cr | up to ₹33.05 Cr |
Sudarshan Pharma Industries IPO opens on Mar 09, 2023, while Systango Technologies IPO opens on Mar 02, 2023. The closing date of Sudarshan Pharma Industries IPO and Systango Technologies IPO is Mar 14, 2023, and Mar 06, 2023, respectively.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Mar 08, 2023 | Mar 01, 2023 |
| Issue Open | Mar 09, 2023 | Mar 02, 2023 |
| Issue Close | Mar 14, 2023 | Mar 06, 2023 |
| Basis Of Allotment (Tentative) | Mar 17, 2023 | Mar 10, 2023 |
| Initiation of Refunds (Tentative) | Mar 20, 2023 | Mar 13, 2023 |
| Credit of Share (Tentative) | Mar 21, 2023 | Mar 14, 2023 |
| Listing date (Tentative) | Mar 22, 2023 | Mar 15, 2023 |
| Anchor Lockin End date 1 | Apr 16, 2023 | Apr 09, 2023 |
| Anchor Lockin End date 2 | Jun 15, 2023 | Jun 08, 2023 |
Sudarshan Pharma Industries IPO P/E ratio is 24.33, as compared to Systango Technologies IPO P/E ratio of 15.13.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 80.28 | 97.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 24.33 | 15.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹175.68 Cr. | ₹132.02 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 17.81 | 49.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 38.59 | 47.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.09 | 0.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.52 | ₹6.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 17.81 | 39.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sudarshan Pharma Industries IPO Retail Individual Investors (RII) are offered 36,51,200 shares while in Systango Technologies IPO retail investors are offered 36,51,200 shares. Qualified Institutional Buyers (QIB) are offered 5,21,600 shares in Sudarshan Pharma Industries IPO and 7,34,400 shares in Systango Technologies IPO.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,80,800 shares | 10,99,200 shares |
| Market Maker Reservation | 3,44,000 shares | 1,96,800 shares |
| QIB | 5,21,600 shares | 7,34,400 shares |
| NII | 15,64,800 shares | 5,52,000 shares |
| RII | 36,51,200 shares | 12,86,400 shares |
| Employee | ||
| Others | ||
| Total | 65,18,400 shares | 36,72,000 shares |
Sudarshan Pharma Industries IPO subscribed 1.06x in total, whereas Systango Technologies IPO subscribed 64.99x.
| Sudarshan Pharma Industries IPO | Systango Technologies IPO | |
|---|---|---|
| QIB (times) | 1.01x | 14.10x |
| NII (times) | 0.81x | 230.36x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.20x | 66.59x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.06x | 64.99x |
